Table 1.
Direct medical cost of Parkinson’s disease by age, gender, insurance coverage, and types of service (in 2017 $s).
| Total excess medical cost due to PD | Per PWP ($) | ||
|---|---|---|---|
| (in Million $s) | Percentage of the total | ||
| Age | |||
| ≤49 | 490 | 2% | 29,346 |
| 50–64 | 4,153 | 16% | 22,598 |
| 65–74 | 8,858 | 35% | 23,011 |
| ≥75 | 11,847 | 47% | 26,222 |
| Gender | |||
| Male | 13,580 | 54% | 22,838 |
| Female | 11,768 | 46% | 26,589 |
| Insurance | |||
| Private | 1,742 | 7% | 22,671 |
| Medicare | 22,793 | 90% | 24,811 |
| Othera | 812 | 3% | 19,489 |
| Type of service | |||
| Non-acute institutional care | 7,144 | 28.2% | 6,888 |
| Hospital inpatient | 7,190 | 28.4% | 6,932 |
| Outpatient | 5,506 | 21.7% | 5,308 |
| Physician office | 1,226 | 4.8% | 1,182 |
| Durable medical equipment | 145 | 0.6% | 140 |
| Prescription medication | 4,137 | 16.3% | 3,988 |
| Overall | 25,348 | 100% | 24,439 |
Source: Authors’ estimation of PD prevalence using 2011–2015 Medical Expenditure Panel Survey (MEPS), 2015 Medicare Current Beneficiary Survey (MCBS), and Census population projections for 2017; combined with direct medical cost estimated using 2016 Optum claims data, 2015 Medicare Standard Analytical File 5% sample claims, and 2015 MCBS.
aOther includes Medicaid, other insurance, and uninsured. Sample size in MEPS did not support further breakdown.